Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia [Phase 2]

View source ↗

Summary

A phase 2 study evaluating the efficacy and safety of ASP4901 in Benign Prostate Hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostate Hyperplasia

Drugs mentioned

• ASP4901

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Benign Prostate Hyperplasia | Phase 2 | Status: COMPLETED